Table 1.
Patients’ characteristics
| Characteristics | N | |
|---|---|---|
| Irradiation | Irradiated Pat. | 107 (70%) |
| Target Vol. | 202 | |
| No Radiation | 46 (30%) | |
| Status | Alive | 77 (50%) |
| Sex | Male | 86 (56%) |
| Female | 67 (44%) | |
| Age (years) | Range 30-87 | 59 median |
| Classification | IgG kappa | 59 (39%) |
| IgG lambda | 25 (16%) | |
| IgA kappa | 21 (14%) | |
| IgA lambda | 15 (10%) | |
| Kappa | 15 (10%) | |
| Lambda | 05 (03%) | |
| Diverse | 13 (08%) | |
| Stage at first diagnosis | I | 21 (14%) |
| (Durie&Salmon [8]) | II | 16 (10%) |
| III A | 99 (65 %) | |
| III B | 17 (11%) | |
| Radiation dose (Gy) | 08 | 02 (01%) |
| 20 | 63 (31%) | |
| 25 | 36 (18%) | |
| 30 | 26 (13%) | |
| 36 | 38 (19%) | |
| 40 | 26 (13%) | |
| Diverse | 11 (05%) | |
| Simultaneous chemotherapy | (with statement about analgesia) | 108 (73) |
| Surgical intervention | 29 (20) |
n = number of patients, Stage = Durie and Salmon.